Caffeine enhances radiosensitization to orthotopic transplant LM3 hepatocellular carcinoma in vivo

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1440-1446

  Wang, Tie Jun ^a   Liu, Zhong Shan ^a   Zeng, Zhao Chong ^a   Du, Shi Suo ^b   Qiang, Ming ^b   Zhang, Shu Min ^b   Zhang, Zheng Yu ^b   Tang, Zhao You ^c   Wu, Wei Zhong ^c   Zeng, Hai Ying ^d  

^a JILIN UNIVERSITY   (China)

^b Department of Radiation Oncology ^*  (China)

^c Liver Cancer Institute   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CASPASE 3; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; RED FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL SURVIVAL; CONTROLLED STUDY; HEPATOMA CELL; IONIZING RADIATION; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANIMALS; APOPTOSIS; CAFFEINE; CDC2 PROTEIN KINASE; CELL LINE, TUMOR; CYCLIN B1; G2 PHASE; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954151135     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01564.x     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Mornex F, Girard N, Beziat C. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006, 66:1152-8.
3. Zeng ZC, Tang ZY, Fan J. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J 2004, 10:307-16. Sudbury, Mass
4. Higuchi K, Mitsuhashi N, Saitoh J. Caffeine enhanced radiosensitivity of rat tumor cells with a mutant-type p53 by inducing apoptosis in a p53-independent manner. Cancer Lett 2000, 152:157-62.
5. Yao SL, Akhtar AJ, McKenna KA. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat Med 1996, 2:1140-3.
6. Palayoor ST, Macklis RM, Bump EA, Coleman CN. Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat Res 1995, 141:235-43.
7. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003, 22:5834-47.
8. Jha MN, Bamburg JR, Bernstein BW, Bedford JS. Caffeine eliminates gamma-ray-induced G2-phase delay in human tumor cells but not in normal cells. Radiat Res 2002, 157:26-31.
9. Sarkaria JN, Busby EC, Tibbetts RS. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999, 59:4375-82.
10. Taylor YC, Parsian AJ, Duncan PG. Differential post-irradiation caffeine response in normal diploid versus SV40-transformed human fibroblasts: potential role of nuclear organization and protein-composition. Int J Radiat Biol 1993, 64:57-70.
11. Blasina A, Paegle ES, McGowan CH. The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol Biol Cell 1997, 8:1013-23.
12. Jin P, Gu Y, Morgan DO. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J Cell Biol 1996, 134:963-70.
13. Smits VA, Medema RH. Checking out the G(2)/M transition. Biochim Biophys Acta 2001, 1519:1-12.
14. Coleman TR, Dunphy WG. Cdc2 regulatory factors. Curr Opin Cell Biol 1994, 6:877-82.
15. Rhind N, Furnari B, Russell P. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev 1997, 11:504-11.
16. Qi W, Qiao D, Martinez JD. Caffeine induces TP53-independent G(1)-phase arrest and apoptosis in human lung tumor cells in a dose-dependent manner. Radiat Res 2002, 157:166-74.
17. Theron T, Bohm L. Cyclin B1 expression in response to abrogation of the radiation-induced G2/M block in HeLa cells. Cell Prolif 1998, 31:49-57.
18. Muschel RJ, Zhang HB, Iliakis G, McKenna WG. Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res 1991, 51:5113-7.
19. Bernhard EJ, Maity A, Muschel RJ, McKenna WG. Increased expression of cyclin B1 mRNA coincides with diminished G2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat Res 1994, 140:393-400.
20. Murnane JP. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective. Cancer Metastasis Rev 1995, 14:17-29.
21. Blanchard J, Sawers SJ. The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 1983, 24:93-8.
22. Li Y, Tang Y, Ye L. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 2003, 129:43-51.
23. Yang BW, Liang Y, Xia JL. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice. Eur J Gastroenterol Hepatol 2008, 20:1077-84.
24. Sun FX, Tang ZY, Lui KD. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer 1996, 66:239-43.
25. Friedrich K, Wieder T, Von Haefen C. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene 2001, 20:2749-60.
26. Prokop A, Wieder T, Sturm I. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia 2000, 14:1606-13.
27. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-9.
28. Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell 1997, 88:315-21.
29. Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 2007, 247:26-39.
30. Lopez-Saez JF, de la Torre C, Pincheira J, Gimenez-Martin G. Cell proliferation and cancer. Histol Histopathol 1998, 13:1197-214.
31. Powell SN, DeFrank JS, Connell P. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 1995, 55:1643-8.
32. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995, 31:1237-48.
33. Antoch G, Kaiser GM, Mueller AB. Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dual-modality PET/CT. Radiology 2004, 230:753-60.